Axios
One of the drug industry’s biggest guardrails against President Trump’s “most favored nation” drug pricing plan is the fact that it’s less enforceable without the involvement of Congress.Why it matters: Enshrining such a policy in law would be proof of GOP evolution on drug prices — or at least the party’s willingness to break with its traditional aversion to government price-setting…
Read More
The future of Trump’s drug pricing plan may run through Congress
Caitlin Owens
16:24
One of the drug industry’s biggest guardrails against President Trump’s “most favored nation” drug pricing plan is the fact that it’s less enforceable without the involvement of Congress.Why it matters: Enshrining such a policy in law would be proof of GOP evolution on drug prices — or at least the party’s willingness to break with
